Table 1.
Heart-failure patients' clinical characteristics and previous drug regimens
| Sex | Age (years) | EF (%) | PCW (mm Hg) | CI (L/min/m2) | ACE-I | AT1 | β-B | DIU | DIG | AMIOD | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ICM | m | 51 | 20-25 | n.a. | n.a. | + | - | - | + | - | - |
| DCM | m | 41 | 25 | 17 | 2.14 | + | - | + | + | - | - |
| DCM | m | 58 | 5-10 | 26 | 2.09 | - | + | + | + | + | - |
| ICM | m | 52 | 15 | n.a. | n.a. | + | - | + | - | - | - |
| ICM | m | 63 | 20 | 20 | 2.24 | + | - | + | + | - | + |
| DCM | f | 57 | 15 | n.a. | 2.21 | - | + | + | + | - | - |
| DCM | m | 32 | 20 | 5 | 2.64 | + | - | + | + | + | - |
| ICM | f | 59 | 23 | 11 | 2.21 | + | - | - | + | - | + |
ACE-I, angiotensin-converting enzyme inhibitor; AMIOD, amiodarone; AT1, AT1-receptor antagonist; β-B, β-blocker; CI, cardiac index; DCM, dilated cardiomyopathy; DIG, digitalis; DIU, diuretic; EF, ejection fraction; ICM, ischemic cardiomyopathy; PCW, pulmonary capillary wedge pressure.